References
Products Transfection
Free Sample Offer
Instruction for Use:
In the „Transfection Reagent Selection Guide“ you can find existing references by setting different filters e.g. for your combination of nucleic acid and cell type. Appropriate keywords in the “Search references“ at the top of the page can also yield a result. A reference indicates that the found transfection reagent has been successfully used for the corresponding application. Ideally, tested transfection parameters and transfection efficiencies are specified.
No reference? > General Selection Guide
If the list does not include a reference concerning your cell type, this does not mean that there is no suitable reagent available, but only that there is no report of experiences with this cell type. In this case it is necessary to preselect (General Selection Guide) and test a reagent (Free Sample Offer). If you want to write an application note for us we will make you an Offer for consideration.
| CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
184A1 |
Human immortalized mammary epithelial cells | ATCC CRL-8798 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | K. Konopka et al., Cell Mol Biol Lett, Jan 2009; 14(1): 70-89 | |||
BT-20 |
Human breast cancer cell line | ATCC HTB-19 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link | |
BT549 |
Human mammary gland cells | ATCC HTB-122 | Human | breast | unknown | adherent | siRNA | RNA-Interference | Metafectene SI | application note | |
||
DU447 |
Human mammary adenocarcinoma cell line | Human | breast | cell line | iron oxide | Metafectene | publication | L. Matuszewski et al., Radiology, Apr 2005; 235: 155 - 161 | |||||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed breast cells | Human | breast | cell line | adherent | plasmid | Metafectene | application note | |
||||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | Metafectene | publication | A. M. Scherbakov et al., J. of Cellular Biochem., 2012, 113: 2147–2155 | ||||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
hMEC |
Human normal mammary epithelial cells | ATCC PCS-600-010 | Human | breast | unknown | adherent | plasmid | Metafectene PRO | application note | |
|||
hMEC |
Human normal mammary epithelial cells | ATCC PCS-600-010 | Human | breast | unknown | adherent | plasmid | Metafectene PRO | application note | |
|||
hMEC |
Human normal mammary epithelial cells | ATCC PCS-600-010 | Human | breast | unknown | adherent | plasmid | Metafectene PRO | publication | A. Ray et al., Mol. Cancer Res., Aug 2011; 9: 1030 - 1041 | Link | ||
HT-1080 |
Human breast fibrocarcinoma cell line | ATCC CCL-121 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | application note | |
|||
HT-1080 |
Human breast fibrocarcinoma cell line | ATCC CCL-121 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | application note | |
|||
HT-1080 |
Human breast fibrocarcinoma cell line | ATCC CCL-121 | Human | breast | cell line | adherent | iron oxide | Metafectene | publication | L. Matuszewski et al., Radiology, Apr 2005; 235: 155 - 161 | |||
M3K |
Drug-resistant breast cancer cell line (derivative of MCF7) | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Thirukkumaran et al., PLOSONE 2017, DOI:10.1371/journal.pone.0168233 | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | K2 Transfection System | publication | C. Actis et al., Cancers, 2021, 13: 1252, doi.org/10.3390/cancers13061252 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | K2 Transfection System | publication | A.-K. Sommer et al., Oncotarget, 2016, 7 (31): 50461 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H. Liu et al., J. Lipid Res., Mar 2013; 54: 776 - 785 | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | B. Ljepoja et al., Scientific Reports, 2018, 8:6927, DOI:10.1038/s41598-018-25240-y | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | I. V. Rassokhina et al., Steroids, 2016, 113: 29-37; doi.org/10.1016/j.steroids.2016.06.001 |









